Wang et al108 found that TET1 played a protective role against non-alcoholic fatty liver disease by promoting fatty acid oxidation through the activation of the peroxisome proliferator-activated receptor alpha (PPARα) pathway. Here, TET1 is linked to metabolic dysfunction-associated steatotic liver disease.